Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2024-08-13

Clinical Trial Update: Adaptive Dengue Antiviral Platform Trial [Phase 2]

View source ↗

Summary

Phase 2 adaptive dengue antiviral platform trial update; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Oxford University Clinical Research Unit, Vietnam | Conditions: Dengue, Antiviral Drugs | Phase 2 | Status: NOT_YET_RECRUITING